Pure Global

IVI-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus - Trial NCT06380868

Access comprehensive clinical trial information for NCT06380868 through Pure Global AI's free database. This phase not specified trial is sponsored by Nanjing First Hospital, Nanjing Medical University and is currently Enrolling by invitation. The study focuses on Diabetes. Target enrollment is 1332 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06380868
Enrolling by invitation
procedure
Trial Details
ClinicalTrials.gov โ€ข NCT06380868
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
IVI-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus
Intravascular Imaging-guided Versus Angiography-guided PCI in Patients With Diabetes Mellitus: the Muticenter, Randomized, Prospective IVI-DIABETES Trial

Study Focus

Diabetes

Intravascular imaging-guided PCI

Interventional

procedure

Sponsor & Location

Nanjing First Hospital, Nanjing Medical University

Nanjing, China

Timeline & Enrollment

N/A

Jun 10, 2024

Jul 20, 2027

1332 participants

Primary Outcome

Rate of target vessel failure (TVF)

Summary

Intravascular ultrasound (IVUS) serves as a beneficial instrument during percutaneous
 coronary intervention (PCI) procedures, affording insight into lesion characteristics and
 stent implantation. The ULTIMATE trial recently evidenced that IVUS-guided Drug-Eluting Stent
 (DES) implantation notably ameliorated clinical outcomes in all-comers, especially in
 patients who underwent an optimal procedure defined by IVUS, as opposed to angiography
 guidance, resonating with findings from the IVUS-XPL study, OCTOBER trial, and RENOVATE
 COMPLEX PCI trial, further confirmed by more recent IVUS-ACS trial.
 
 Optical coherence tomography (OCT) has a resolution 10 times higher than that of IVUS and can
 provide valuable information at each step of PCI.
 
 Regrettably, a dearth of prospective, randomized, multicenter trials exists that scrutinize
 the benefits of IVI-guided as opposed to angiography-guided PCI in patients suffering from
 diabetes mellitus. However, several trials have presented subgroup analyses reporting the
 reduction of clinical events by IVUS but not OCT guidance in patients with diabetes mellitus,
 which served as the foundation for the design of this trial.

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Other specified diabetes mellitus without complications

Data Source

ClinicalTrials.gov

NCT06380868

Non-Device Trial